Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Anagenics ( (AU:AN1) ) has provided an announcement.
Anagenics Limited announced a change in the director’s interest, with Alexander Beard acquiring an additional 55,564 fully paid ordinary shares through an on-market purchase. This acquisition reflects a slight increase in Beard’s indirect shareholding, indicating a potential vote of confidence in the company’s future prospects and stability.
More about Anagenics
Anagenics Limited operates in the biotechnology industry, focusing on the development and commercialization of innovative health and wellness products. The company is primarily involved in producing and marketing products that cater to consumer health needs.
Current Market Cap: A$2.98M
Learn more about AN1 stock on TipRanks’ Stock Analysis page.